Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Organogenesis Hldgs Inc (ORGO)

117 + Investors. Track Smart Money conviction in ORGO. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -26
Streak
1Q ▼
Buyers last Q
38%

Smart Money Signals — ORGO

Based on 118 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their ORGO positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
📊

High ownership — 82% of 3.0Y peak

82% of all-time peak
118 funds currently hold this stock — 82% of the 3.0-year high of 144 funds (reached 2025 Q4). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
📉

Outflows — 12% fewer funds vs a year ago

fund count last 6Q
16 fewer hedge funds hold ORGO compared to a year ago (-12% decline). When institutions consistently reduce their exposure, it's worth exploring the underlying fundamental reasons driving them away.
🔴

Heavy selling pressure — only 38% buying

53 buying88 selling
Last quarter: 88 funds sold vs only 53 buyers. This is widespread institutional distribution — not a few funds rebalancing, but a broad exit. High conviction bearish signal.
⚠️

Fewer new buyers each quarter (-20 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 21 → 22 → 36 → 16. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔒

55% of holders stayed for 2+ years

■ 55% conviction (2yr+) ■ 27% medium ■ 18% new
65 out of 118 hedge funds have held ORGO for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares -11%, value -61%

Value
-60%
Shares
-10%
Last quarter: funds added -11% more shares while total portfolio value only changed -61%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
📈

Growing discovery — still being found

29 → 21 → 22 → 36 → 16 new funds/Q
New funds entering each quarter: 21 → 22 → 36 → 16. A growing number of institutions are discovering ORGO each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Veteran-anchored — 65% veterans vs 23% newcomers

■ 65% veterans ■ 13% 1-2yr ■ 23% new
Entry-cohort mix of 119 holders: 77 (65%) are 2+ year veterans, 15 entered 1–2 years ago, and 27 (23%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 46% AUM from top-100 funds

46% from top-100 AUM funds
33 of 118 holders are among the 100 largest funds by AUM, controlling 46% of total institutional value in ORGO. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
3.3
out of 10
Low Exit Risk
Exit risk score 3.3/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — ORGO

In 2026 Q1, 53 hedge funds were net buyers of ORGO (16 opened a new position, 37 added to an existing one), while 88 reduced or exited (46 trimmed, 42 sold completely) — a 38% buyer ratio, indicating net institutional distribution. 46% of total institutional value in ORGO is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: -26 funds (more exits than new entries). Total institutional holders: 118.

Hedge Fund Ownership: ORGO

How many hedge funds hold ORGO — quarterly history vs. share price
Quarterly hedge fund ownership of ORGO vs. share price

Market Analysis: ORGO

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: ORGO

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Organogenesis Hldgs Inc (ORGO) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much ORGO has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 76d ago
ORGO
+1.7%
XLV
+4.5%

ORGO outperformed XLV by -2.8% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 31d ago
ORGO
+0.0%
XLV
+5.6%

Since the filing became public, ORGO outperformed XLV by -5.6% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

17 top-rated funds 1 high-conviction
Consensus
5.5
/ 10
breadth
×
Elite
1.1
/ 10
conviction
Hedge Fund Positioning: ORGO
117 + Investors

Track Smart Money conviction in ORGO. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 117 144 -18.75%
13F Shares 62M 70M -10.75%
Total Value $141M $359M -60.68%
New Positions 15 36 -21
Increased Positions 35 44 -9
Closed Positions 42 10 +32
Reduced Positions 46 43 +3
Total Calls 1 1 -
Total Puts 0 1 -100.0%
PUT/CALL Ratio 0.0 1.0 Bullish

Statistics: ORGO

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

117 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ORGO. Verified SEC 13F-HR filings.

QUARTER:
Top 25 ORGO holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 PharVision Advisers, LLC 11.86% 16,302 $39K
2 Soleus Capital Management, L.P. 0.97% 10,085,951 $23.9M
3 Flax Pond Capital, LLC 0.80% 420,091 $996K
4 First Light Asset Management, LLC 0.74% 3,498,533 $8.3M
5 HighMark Wealth Management LLC 0.29% 303,029 $718K
6 Sphera Funds Management LTD. 0.21% 550,000 $1.3M
7 Wealth Dimensions Group, Ltd. 0.19% 407,965 $967K
8 Intrepid Family Office LLC 0.14% 73,580 $174K
9 Oxford Asset Management LLP 0.04% 37,842 $90K
10 Palumbo Wealth Management LLC 0.03% 57,849 $137K
11 Capital Square, LLC 0.02% 19,113 $45K
12 Hennion & Walsh Asset Management, Inc. 0.02% 210,826 $500K
13 Segall Bryant & Hamill, LLC 0.01% 318,773 $851K
14 Assenagon Asset Management S.A. 0.01% 1,967,952 $4.7M
15 Truvestments Capital LLC 0.01% 13,323 $32K
16 ExodusPoint Capital Management, LP 0.01% 276,914 $656K
17 Ethos Financial Group, LLC 0.00% 12,987 $67K
18 Los Angeles Capital Management LLC 0.00% 491,841 $1.2M
19 Renaissance Technologies LLC 0.00% 1,068,538 $2.5M
20 D. E. Shaw & Co., Inc. 0.00% 2,297,974 $5.4M
21 Nwam LLC 0.00% 20,000 $47K
22 Prelude Capital Management, LLC 0.00% 14,008 $33K
23 State of Wisconsin Investment Board 0.00% 456,367 $1.1M
24 Bailard, INC. 0.00% 36,812 $87K
25 Pallas Capital Advisors LLC 0.00% 18,685 $44K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Organogenesis Hldgs Inc (ORGO)

What does the Smart Money Trend signal show for ORGO?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their ORGO positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for ORGO?

Heavy selling pressure — only 38% buying: Last quarter: 88 funds sold vs only 53 buyers. This is widespread institutional distribution — not a few funds rebalancing, but a broad exit. High conviction bearish signal.

What is the fund quality score for ORGO holders?

Elite ownership — 46% AUM from top-100 funds: 33 of 118 holders are among the 100 largest funds by AUM, controlling 46% of total institutional value in ORGO. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held ORGO?

55% of holders stayed for 2+ years: 65 out of 118 hedge funds have held ORGO for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Organogenesis Hldgs Inc (ORGO) following the 2026 Q1 hedge fund 13F filings?

As of today, ORGO has moved +0.0% since the 2026 Q1 13F filing date (May 15, 2026), compared to +5.6% for the XLV sector ETF — an outperformance of -5.6%. Since the quarter end (March 31, 2026), ORGO has gained +1.7% vs +4.5% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →